Should Continuous Infusion 5-Fluorouracil Become the Standard of Care in the USA as It Is in Europe?

By El-Khoueiry Anthony   Lenz Heinz-Josef  

Cancer Investigation, Vol. 24, Iss. 1, 2006-03 ,pp. : 50-55

Informa Healthcare

Access to resources Recommend Favorite

Low-dose continuous 5-fluorouracil infusion stimulates VEGF-A-mediated angiogenesis

By Albertsson Per   Lennernas Bo   Norrby Klas  

Acta Oncologica, Vol. 48, Iss. 3, 2009-04 ,pp. : 418-425

Informa Healthcare

Access to resources Recommend Favorite

Squamous Oesophageal Cancer can be Downstaged Using Protracted Venous Infusion of 5-Fluorouracil with Epirubicin and Cisplatin (ECF)

By Andreyev H.J.N.   Norman A.R.   Cunningham D.   Padhani A.R.   Hill A.S.   Ross P.J.   Webb A.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2209-2214

Elsevier

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma

By Ueno Hideki   Okada Shuichi   Okusaka Takuji   Ikeda Masafumi   Kuriyama Hitoshi  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite

Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil

By Sai Heitetsu   Mitsumori Michihide   Yamauchi Chikako   Araki Norio   Okumura Setsuko   Nagata Yasushi   Nishimura Yasumasa   Hiraoka Masahiro  

International Journal of Clinical Oncology, Vol. 9, Iss. 3, 2004-06 ,pp. : 149-153

Springer Publishing Company

Access to resources Recommend Favorite